Plasma viscosity in giant cell arteritis

Eur Neurol. 2011;66(3):159-64. doi: 10.1159/000331059. Epub 2011 Sep 1.

Abstract

Background: Diagnosis of giant cell arteritis (GCA) is based on criteria of the American College of Rheumatology. However, not all GCA patients meet these criteria and treatment may be delayed in individual patients, leading to an increased risk of complications.

Methods: In an observational study, we investigated acute phase response markers in GCA and non-GCA patients matched for erythrocyte sedimentation rate and CRP levels.

Results: Plasma viscosity (PV) was significantly elevated in all GCA patients, but normal in non-GCA patients.

Conclusions: Our data suggest that PV may reflect a more specific component of the acute inflammatory response in patients with GCA. Analysis of PV may significantly contribute to a reliable diagnosis early in the course of the disease, particularly in patients with suspected GCA that do not meet current diagnostic criteria.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • Blood Sedimentation
  • Blood Viscosity* / drug effects
  • C-Reactive Protein / metabolism
  • Female
  • Giant Cell Arteritis / blood*
  • Giant Cell Arteritis / diagnosis
  • Giant Cell Arteritis / drug therapy
  • Group II Phospholipases A2
  • Humans
  • Male
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Statistics as Topic
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • C-Reactive Protein
  • Group II Phospholipases A2
  • Methylprednisolone